Morgan Stanley analyst Matthew Harrison maintains Seagen (NASDAQ:SGEN) with a Overweight and lowers the price target from $181 to $170.
Morgan Stanley Maintains Overweight on Seagen, Lowers Price Target to $170
Morgan Stanley analyst Matthew Harrison maintains Seagen (NASDAQ:SGEN) with a Overweight and lowers the price target from $181 to $170.
Related Posts
Disney’s Crown Jewels Off-Limits: CEO Bob Iger Declares Marvel, Star Wars Won’t Go to Netflix
November 9, 1:17 AM
Iger said that Disney, Pixar, Marvel, and Star Wars genuinely represent substantial competitive benefits for Disney.
DXC Technology And ServiceNow Expand Partnership For Digital Workflow Advancements
November 28, 11:18 AM
DXC Technology Company (NYSE: DXC) and ServiceNow Inc (NYSE: NOW) announced an enhanced
The Latest Analyst Ratings for South Plains Financial
July 26, 1:00 PM
Analysts have provided the following ratings for South Plains Financial (NASDAQ:SPFI) within the last quarter: Bullish Somewhat Bullish…